Log in
Enquire now
‌

US Patent 10196444 Multipartite signaling proteins and uses thereof

Patent 10196444 was granted and assigned to Bluebird Bio on February, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Bluebird Bio
Bluebird Bio
Current Assignee
Bluebird Bio
Bluebird Bio
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10196444
Date of Patent
February 5, 2019
Patent Application Number
14908734
Date Filed
July 23, 2014
Patent Citations Received
0
‌
US Patent 11384090 Spiropyrrolidine derived antiviral agents
‌
US Patent 11952413 Dimerizing agent regulated immunoreceptor complexes comprising interleukin receptor signaling domains
0
‌
US Patent 11976084 Spiropyrrolidine derived antiviral agents
0
‌
US Patent 10457731 Multipartite signaling proteins and uses thereof
‌
US Patent 11530265 Multipartite signaling proteins and uses thereof
‌
US Patent 11319325 Macrocyclic spiropyrrolidine derived antiviral agents
‌
US Patent 11325916 Spiropyrrolidine derived antiviral agents
...
Patent Primary Examiner
‌
Shin-Lin Chen
Patent abstract

The present disclosure relates to compositions and methods for using cells having chemically-induced fusion protein complexes to spatially and temporally control immune cell signal initiation and downstream responses for treating disease.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10196444 Multipartite signaling proteins and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.